Citigroup’s Relmada Therapeutics RLMD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1 | Hold |
2
| – | – | ﹤0.01% | 4865 |
|
|
2025
Q1 | $1 | Sell |
2
-62,947
| -100% | -$31.5K | ﹤0.01% | 4737 |
|
|
2024
Q4 | $32.7K | Sell |
62,949
-2
| -0% | -$1 | ﹤0.01% | 4340 |
|
|
2024
Q3 | $204K | Hold |
62,951
| – | – | ﹤0.01% | 3569 |
|
|
2024
Q2 | $189K | Sell |
62,951
-60,862
| -49% | -$183K | ﹤0.01% | 3184 |
|
|
2024
Q1 | $576K | Buy |
123,813
+50,690
| +69% | +$236K | ﹤0.01% | 2759 |
|
|
2023
Q4 | $303K | Sell |
73,123
-26,400
| -27% | -$109K | ﹤0.01% | 2992 |
|
|
2023
Q3 | $299K | Sell |
99,523
-19,795
| -17% | -$59.4K | ﹤0.01% | 2752 |
|
|
2023
Q2 | $294K | Buy |
+119,318
| New | +$294K | ﹤0.01% | 3036 |
|
|
2023
Q1 | – | Sell |
-185
| Closed | -$646 | – | 4899 |
|
|
2022
Q4 | $646 | Sell |
185
-3,997
| -96% | -$14K | ﹤0.01% | 4678 |
|
|
2022
Q3 | $155K | Sell |
4,182
-58,519
| -93% | -$2.17M | ﹤0.01% | 3186 |
|
|
2022
Q2 | $1.19M | Buy |
62,701
+27,796
| +80% | +$528K | ﹤0.01% | 1959 |
|
|
2022
Q1 | $942K | Buy |
34,905
+29,891
| +596% | +$807K | ﹤0.01% | 2402 |
|
|
2021
Q4 | $113K | Sell |
5,014
-2,887
| -37% | -$65.1K | ﹤0.01% | 3907 |
|
|
2021
Q3 | $207K | Buy |
7,901
+4,166
| +112% | +$109K | ﹤0.01% | 3366 |
|
|
2021
Q2 | $120K | Buy |
3,735
+1,975
| +112% | +$63.5K | ﹤0.01% | 3786 |
|
|
2021
Q1 | $62K | Sell |
1,760
-2,748
| -61% | -$96.8K | ﹤0.01% | 3940 |
|
|
2020
Q4 | $144K | Buy |
4,508
+1,909
| +73% | +$61K | ﹤0.01% | 3437 |
|
|
2020
Q3 | $98K | Sell |
2,599
-2,423
| -48% | -$91.4K | ﹤0.01% | 3149 |
|
|
2020
Q2 | $224K | Buy |
5,022
+3,322
| +195% | +$148K | ﹤0.01% | 3020 |
|
|
2020
Q1 | $58K | Buy |
1,700
+764
| +82% | +$26.1K | ﹤0.01% | 3681 |
|
|
2019
Q4 | $37K | Buy |
+936
| New | +$37K | ﹤0.01% | 4174 |
|